Trader consensus against a Trump pardon for Ghislaine Maxwell by the end of 2026 stems primarily from the political toxicity of clemency for the convicted sex-trafficking associate of Jeffrey Epstein, whose case continues to draw intense public and congressional scrutiny. Maxwell has exhausted most appellate avenues, with a federal judge recently rejecting her latest petition as largely meritless, leaving a presidential pardon or commutation as her principal remaining option. Senate passage of a unanimous resolution opposing any such action, statements from administration officials declining to recommend clemency, and White House indications that the matter is not under active consideration reinforce the low implied probability. Bipartisan pressure from victims’ advocates and lawmakers further raises the cost of granting relief. Realistic shifts could still arise from late-term calculations during the final months of the term, new cooperation offers tied to sealed files, or unforeseen developments in related investigations, though no formal clemency request has advanced to date.